High Dose Vitamin D and MS Relapse: New Phase 3 Data : vimar

Data from a phase 3 trial suggest high-dose vitamin D does not prevent relapse in patients with RRMS. However, at least one expert suggests the study's exclusion criteria may have been too broad.

Related Keywords

Maryland , United States , Baltimore , Boston , Massachusetts , Johns Hopkins University , Francesw Johnson , Alberto Ascherio , Ellen Mowry , Johns Hopkins University School Of Medicine , , Johns Hopkins University School , Medscape Medical , Relapse Risk , Kurtzke Expanded Disability Status , Medscape Medical News , Public Health , Multiple Sclerosis Ms , Multiple Sclerosis , Us , Vitamins , Multiple Sclerosis Progression , Als Progression , Multiple Sclerosis Treatment , Als Treatment , Reatment Of Multiple Sclerosis , Reatment Of Ms , Multiple Sclerosis Imaging , S Imaging , Maging In Multiple Sclerosis , Maging In Ms , Maging Studies In Multiple Sclerosis , Maging Studies In Ms , Vitamind Deficiency , Ms Lesion , Ultiple Sclerosis Lesio ,